Instil Bio, Inc.
TIL
$15.46
$0.1551.01%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -74.14M | -75.17M | -119.58M | -123.32M | -156.09M |
| Total Depreciation and Amortization | 3.61M | 3.91M | 3.96M | 3.97M | 4.76M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 27.43M | 22.32M | 61.83M | 60.97M | 78.32M |
| Change in Net Operating Assets | -12.61M | -9.58M | 976.00K | -3.38M | -9.02M |
| Cash from Operations | -55.70M | -58.52M | -52.81M | -61.76M | -82.03M |
| Capital Expenditure | -- | -58.00K | -5.22M | -12.20M | -20.66M |
| Sale of Property, Plant, and Equipment | 866.00K | 2.10M | 2.10M | 1.56M | 1.56M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 53.11M | 52.88M | 40.55M | 46.48M | 60.23M |
| Cash from Investing | 53.97M | 54.92M | 37.43M | 35.84M | 41.13M |
| Total Debt Issued | 85.60M | 0.00 | 0.00 | 4.20M | 8.67M |
| Total Debt Repaid | -82.84M | 0.00 | -587.00K | -587.00K | -587.00K |
| Issuance of Common Stock | 365.00K | 159.00K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.37M | -- | -- | -- | -- |
| Cash from Financing | 1.76M | 159.00K | -587.00K | 3.62M | 8.08M |
| Foreign Exchange rate Adjustments | -94.00K | -48.00K | -175.00K | -240.00K | -201.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -61.00K | -3.48M | -16.14M | -22.54M | -33.02M |